Develops medical devices that use electric fields to kill cancer cells.
Jun 2026Revenue $699M/yrExpenses $854M/yr
No trendCash runway ≈ 3.7 years from Jun 2026
Figures by year
When will NovoCure be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $699M and expenses $854M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $655M | $809M | −$154M |
| Dec 2024 | $605M | $776M | −$170M |
| Dec 2023 | $509M | $742M | −$233M |
| Dec 2022 | $538M | $627M | −$89.5M |
| Dec 2021 | $535M | $579M | −$44.3M |
| Dec 2020 | $494M | $464M | $30.4M |
| Dec 2019 | $351M | $352M | −$914K |
| Dec 2018 | $248M | $282M | −$33.7M |
| Dec 2017 | $177M | $216M | −$39.3M |
| Dec 2016 | $82.9M | $198M | −$115M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.